Bench AJ - Search Results

1

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia.

Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. Huntly BJ, et al. Among authors: bench aj. Blood. 2001 Sep 15;98(6):1732-8. doi: 10.1182/blood.v98.6.1732. Blood. 2001. PMID: 11535505 Free article.

2

Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia.

Huntly BJ, Bench A, Green AR. Huntly BJ, et al. Blood. 2003 Aug 15;102(4):1160-8. doi: 10.1182/blood-2003-01-0123. Epub 2003 May 1. Blood. 2003. PMID: 12730117 Free article. Review.

3

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability.

Huntly BJ, Bench AJ, Delabesse E, Reid AG, Li J, Scott MA, Campbell L, Byrne J, Pinto E, Brizard A, Niedermeiser D, Nacheva EP, Guilhot F, Deininger M, Green AR. Huntly BJ, et al. Among authors: bench aj. Blood. 2002 Jun 15;99(12):4547-53. doi: 10.1182/blood.v99.12.4547. Blood. 2002. PMID: 12036887 Free article.

4

Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia.

Fourouclas N, Campbell PJ, Bench AJ, Swanton S, Baxter EJ, Huntly BJ, Green AR. Fourouclas N, et al. Among authors: bench aj. Haematologica. 2006 Jul;91(7):952-5. Haematologica. 2006. PMID: 16818283

5

Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia.

Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR. Sinclair PB, et al. Blood. 2000 Feb 1;95(3):738-43. Blood. 2000. PMID: 10648381 Free article.

6

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms.

Anand S, Stedham F, Beer P, Gudgin E, Ortmann CA, Bench A, Erber W, Green AR, Huntly BJ. Anand S, et al. Blood. 2011 Jul 7;118(1):177-81. doi: 10.1182/blood-2010-12-327593. Epub 2011 May 11. Blood. 2011. PMID: 21562050 Free article.

7

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

Campbell PJ, Baxter EJ, Beer PA, Scott LM, Bench AJ, Huntly BJ, Erber WN, Kusec R, Larsen TS, Giraudier S, Le Bousse-Kerdilès MC, Griesshammer M, Reilly JT, Cheung BY, Harrison CN, Green AR. Campbell PJ, et al. Among authors: bench aj. Blood. 2006 Nov 15;108(10):3548-55. doi: 10.1182/blood-2005-12-013748. Epub 2006 Jul 27. Blood. 2006. PMID: 16873677 Free article.

8

Rescue of the lethal scl(-/-) phenotype by the human SCL locus.

Sinclair AM, Bench AJ, Bloor AJ, Li J, Göttgens B, Stanley ML, Miller J, Piltz S, Hunter S, Nacheva EP, Sanchez MJ, Green AR. Sinclair AM, et al. Among authors: bench aj. Blood. 2002 Jun 1;99(11):3931-8. doi: 10.1182/blood.v99.11.3931. Blood. 2002. PMID: 12010791 Free article.

9

Pathogenesis of polycythaemia vera.

Hinshelwood S, Bench AJ, Green AR. Hinshelwood S, et al. Among authors: bench aj. Blood Rev. 1997 Dec;11(4):224-32. doi: 10.1016/s0268-960x(97)90021-7. Blood Rev. 1997. PMID: 9481451 Review.

10

Molecular genetics and cytogenetics of myeloproliferative disorders.

Bench AJ, Nacheva EP, Champion KM, Green AR. Bench AJ, et al. Baillieres Clin Haematol. 1998 Dec;11(4):819-48. doi: 10.1016/s0950-3536(98)80041-3. Baillieres Clin Haematol. 1998. PMID: 10640219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page